Dedicated Nurse Navigators are available to support patients on every step of their treatment journey
A free supply of ZEPOSIA for up to 24 months to qualified, commercially insured patients who are at risk of an interruption in therapyb
Helps patients with co-pay costs, including prescription and medical assessment/initiation costsc
CoverMyMeds offers access to multiple, integrated services — including electronic Prior Authorization (ePA) support for prescribers — that help simplify processes and access for patients prescribed ZEPOSIA. To begin the process online visit covermymeds®.
aFor patients with commercial coverage in all states except MA, MN, and RI.
bThe Bridge Program is available at no cost for eligible commercially insured, on-label diagnosed patients if there is a delay in determining whether commercial prescription coverage is available, and is not contingent on any purchase requirement. The Bridge Program is not available to patients who have prescription insurance coverage through Medicare, Medicaid, or any other federal or state program, or MI residents, and is available for no more than 12 months (365 days) to patients in MA, MN, and RI. Appeal of any prior authorization denial must be made within 90 days or as per payer guidelines, to remain in the Program. Eligibility will be re-verified in January for patients continuing into the following year, and may be at other times during Program participation. Up to 12 additional refills may be provided if needed. Offer is not health insurance, and may be modified or discontinued at any time without notice. Other limitations may apply.
cDepending on insurance coverage and where the full cost is not covered by patient’s insurance, eligible patients may receive a prescription benefit offer for out-of-pocket drug costs and pay as little as $0 per prescription, as well as a medical assessment benefit offer for out-of-pocket costs for the initial blood tests, ECG screening, and Macular Edema screening (if required) . Maximum savings limit applies; patient out-of-pocket expenses may vary. This program is not health insurance. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state health care programs. Please visit ZEPOSIA.com/copayterms for Program Terms, Conditions, and Eligibility Criteria. Medical co-pay benefit not available for residents of MA, MN, and RI.
ICD Code: For reimbursement purposes, the ICD-10-CM code for patients with a multiple sclerosis diagnosis is G35.
aBased on Weekly Field Intelligence Input and MMIT, as of November 2021.
Step 1: Find ZEPOSIA coverage by location
Step 2: Filter results by health plan/pharmacy benefit manager (PBM) type
Find ZEPOSIA coverage by health plan/PBM
Choose your health plan/PBM
No results found
Provides a comprehensive look at ZEPOSIA for patients and outlines steps to get them started on therapy
Provides a streamlined version of the Patient Decision Kit, including a quick overview of ZEPOSIA and ZEPOSIA 360 Support™
Helps your patients not currently receiving any therapy get started on ZEPOSIA
Enables you to advocate for patients who are currently receiving therapy, if they receive an unfavorable coverage decision
Enables you to advocate for patients who are not currently receiving therapy, if they receive an unfavorable coverage decision
This information is intended for U.S. Healthcare Professionals.